Companies:
50,243
Total Market Cap:
139145596312678.92
Global Rank
#37046
Country Rank
#456
Market Cap
18.77 M
Price
1.47
Change (%)
0.78%
Volume
1,238
NFL Biosciences SA's latest marketcap:
18.77 M
As of 08/04/2025, NFL Biosciences SA's market capitalization has reached $18.77 M. According to our data, NFL Biosciences SA is the 37046th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 18.77 M |
| Revenue (ttm) | 53.14 |
| Net Income (ttm) | -2,403,785.21 |
| Shares Out | 12.67 M |
| EPS (ttm) | -0.24 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 03/28/2025 |
Market Cap Chart
Data Updated: 08/04/2025
NFL Biosciences SA's yearly market capitalization.
NFL Biosciences SA has seen its market value grow from €12.56 M to €16.25 M since 2021, representing a total increase of 29.31% and an annual compound growth rate (CAGR) of 7.42%.
| Date | Market Cap(€) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/04/2025 | €16.25 M | $18.77 M | -12.91% | 37046 |
| 12/31/2024 | €19.12 M | $19.79 M | 63.78% | 34228 |
| 12/29/2023 | €11.67 M | $12.88 M | 13.49% | 35981 |
| 12/30/2022 | €10.29 M | $11.01 M | -18.12% | 35560 |
| 12/31/2021 | €12.56 M | $14.28 M | 34256 |
Company Profile
About NFL Biosciences SA
NFL Biosciences SA is a biotechnology company focused on developing natural addiction withdrawal solutions, particularly for smokers.
Pipeline Highlights
- NFL-101: A smoking cessation drug candidate currently in Phase 2b clinical trials.
- NFL-201: A preclinical-stage drug candidate targeting cannabis addiction.
- NFL-301: A preclinical-stage drug candidate aimed at reducing alcohol consumption.
Company Background
Founded in 2006, NFL Biosciences SA is headquartered in Castelnau-le-Lez, France.
Frequently Asked Questions
-
What is NFL Biosciences SA's (EPA-ALNFL) current market cap?As of 08/04/2025, NFL Biosciences SA (including the parent company, if applicable) has an estimated market capitalization of $18.77 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does NFL Biosciences SA (EPA-ALNFL) rank globally by market cap?NFL Biosciences SA global market capitalization ranking is approximately 37046 as of 08/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.